NIKKEI 225
38,274.12 +0.07 (+0.00%) HANG SENG
18,201.74 +438.71 (+2.47%) CRUDE OIL
79.55 +0.55 (+0.70%) GOLD FUTURES
2,324.70 +13.70 (+0.59%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,815.71 -2,018.84 (-4.22%)
Inari Medical, Inc. (NARI)
After hours:
| Previous close | 37.34 |
| Open | 42.00 |
| Bid | 41.52 x 200 |
| Ask | 41.65 x 100 |
| Day's range | 41.36 - 45.41 |
| 52-week range | 36.73 - 71.85 |
| Volume | |
| Avg. volume | 1,340,986 |
| Market cap | 2.419B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Inari Medical Reports First Quarter 2024 Financial Results
IRVINE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its first quarter ended March 31, 2024. First Quarter Financial and Recent Business Highlights Generated revenue of $143.2 million in Q1 of 2024, up 23.3% over the same quarter last year.GAAP operating loss was $17.2 million in Q1 of 2024,
- GlobeNewswire
Inari Medical to Announce First Quarter 2024 Financial Results
IRVINE, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its first quarter 2024 financial results on Tuesday, April 30, 2024. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and rec
- GlobeNewswire
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the publication of its 2023 Ethos and Sustainability Report. The report highlights Inari’s commitment to its ethos and important corresponding environmental, social and governance (ESG) initiatives. The report can be found on Inari’s website here. “We are prou
